BUX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $33,012.48
Insider Selling (Last 12 Months): $0.00

Biomark Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Biomark Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biomark Diagnostics Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 07/9/2020 01:00 AM ET

This chart shows the closing price history over time for BUX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

SEC Filings (Institutional Ownership Changes) for Biomark Diagnostics (CNSX:BUX)

Biomark Diagnostics logo
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Read More on Biomark Diagnostics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

11,500 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Biomark Diagnostics?

Biomark Diagnostics' top insider shareholders include:
  1. Guoyu Huang (Senior Officer)
  2. Rashid Ahmed Maula Bux (Director)
Learn More about top insider investors at Biomark Diagnostics.